Pinnaql

Based in the US, Pinnaql, Inc. provides end-to-end solutions for the life sciences sector, particularly in pharmaceuticals, biotechnology, and medical devices, ensuring compliance and operational excellence. Pinnaql, Inc. specializes in delivering solutions tailored for the life sciences sector.

Founded in 2019 in the United States, the company has maintained a consistent focus on enhancing operational efficiencies for clients. It has successfully completed one deal, with the most recent transaction occurring on June 17, 2025. The founder's history prior to Pinnaql is not publicly detailed. Pinnaql specializes in providing comprehensive solutions to the life sciences sector, focusing on pharmaceutical, biotechnology, and medical device industries.

Their core offerings include project management, quality systems development, compliance support, lab asset lifecycle management, automation, and manufacturing engineering/validation. By leveraging deep expertise in Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and associated regulatory frameworks, Pinnaql serves a diverse clientele, including Contract Development and Manufacturing Organizations (CDMOs), compounding pharmacies, and enterprises involved in advanced therapies such as gene and cell therapy. The company's services are designed to enhance quality, streamline operations, and accelerate development timelines, facilitating the transition from lab innovation to market launch. Pinnaql caters to clients across North America and Europe, ensuring that their solutions adhere to the highest regulatory standards while addressing the specific challenges faced in these regions.

Pinnaql's revenue structure is built on a B2B model, where they engage directly with clients in the life sciences sector to deliver tailored services that meet specific operational needs. Transactions typically involve long-term partnerships focused on quality systems implementation, compliance audits, and manufacturing support, with varying service agreements based on project scope and client requirements. The company offers customized solutions that may include subscription-based quality management systems and one-off consulting engagements for regulatory compliance and validation services. Each client engagement is structured to deliver value through process optimization, risk mitigation, and enhanced operational efficiency.

Pinnaql’s revenue is generated from these specialized services, which are vital for clients aiming to maintain regulatory compliance and drive innovation in their product development efforts. In June 2025, Pinnaql, Inc. was acquired by LSOMS Holdings, L. P.

, a portfolio company of 3 Boomerang Capital. The acquisition aims to enhance LSOMS Holdings, L. P. 's compliance and validation service offerings.

The strategic direction post-acquisition may include development of new products and expansion into new markets, although specific details have not been disclosed. Funding from this acquisition will likely support the enhancement of service offerings and operational capabilities.